Detalhe da pesquisa
1.
Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia.
Blood
; 130(17): 1911-1922, 2017 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28835438
2.
Accelerated Development With Increased Bone Mass and Skeletal Response to Loading Suggest Receptor Activity Modifying Protein-3 as a Bone Anabolic Target.
Front Endocrinol (Lausanne)
; 12: 807882, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35095771
3.
SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3-ITD-mutant AML.
Blood Adv
; 5(9): 2412-2425, 2021 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33956058
4.
Research resource: Haploinsufficiency of receptor activity-modifying protein-2 (RAMP2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in mice.
Mol Endocrinol
; 25(7): 1244-53, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21566080